Skip to navigation Skip to content



Blood Pressure Medication Prevents Myelin Damage and Reduces MS-like Symptoms in Mice

March 13, 2015

Researchers at the University of Chicago report that the blood pressure medication guanabenz increases the survival of myelin-making cells and reduces symptoms in MS-like disease in mice. First author Sharon Way, PhD, was funded in this work by a postdoctoral fellowship from the National MS Society, supported in part by the Dave Tomlinson Research Fund. The medication is now being tested for its potential to treat people with MS.

Read more on Medical Xpress.
Read the study, reported in Nature Communications.
Read more about research to repair damage in MS.

About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system. Symptoms range from numbness and tingling to blindness and paralysis, and there is currently no cure for MS. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. An estimated 1 million people live with MS in the United States. Most people with MS are diagnosed between the ages of 20 and 50, and it affects women three times more than men.


© 2020 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.